No Difference In Highly Active Antiretroviral Therapy Between HIV-infected Injection Drug Users And Non-users

An article published in a special HIV/AIDS issue of JAMA on August 6 reports that there is little difference in the survival rates between injection drug users (IDUs) and non-injection drug users (non-IDUs) who receive highly active antiretroviral therapy (HAART) for four to five years. This research, conducted by Julio S. G. Montaner, M.D., F.R.C.P.C., (University of British Columbia and St.

More: continued here

Filed under: Alcohol / Addiction / Illegal Drugs on August 7th, 2008